Loading clinical trials...
Loading clinical trials...
Prospective, non-randomized, multicenter post-approval study to collect long term clinical and echographic data on Mitroflow DL patients.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
LivaNova
NCT06638268 · Aortic Stenosis, Cardiogenic Shock
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07469371 · Severe Aortic Stenosis
NCT07278310 · Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis
NCT07453407 · Aortic Regurgitation, Aortic Valve Insufficiency, and more
UCLA Medical Center
Los Angeles, California
Sharp Memorial Hospital
San Diego, California
River City Clinical Research
Jacksonville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions